Skip to main content
Samuel Bakhoum, MD, Radiation Oncology, New York, NY

Samuel F Bakhoum MD Ph.D.


Resident Physician

Join to View Full Profile
  • 1275 York AvenueNew York, NY 10065

Dr. Bakhoum is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • https://www.mskcc.org/cancer-care/doctors/samuel-bakhoum

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterResidency, Radiation Oncology, 2014 - 2018
  • Mount Auburn Hospital
    Mount Auburn HospitalInternship, Preliminary Year, 2013 - 2014
  • Geisel School of Medicine at Dartmouth
    Geisel School of Medicine at DartmouthClass of 2013, MD-PhD

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2023 - Present
  • NY State Medical License
    NY State Medical License 2014 - 2028
  • NC State Medical License
    NC State Medical License 2021 - 2022
  • MA State Medical License
    MA State Medical License 2013 - 2014
  • Radiation Oncology
    American Board of Radiology Radiation Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • A Markov Chain for Numerical Chromosomal Instability in Clonally Expanding Populations  
    Samuel Bakhoum, MD, PLoS One
  • Insights into Clonal Haematopoiesis from 8,342 Mosaic Chromosomal Alterations  
    Samuel F Bakhoum, Yakir A Reshef, Nature

Press Mentions

  • This “Chaos Enzyme” May Hold the Key to Stopping Cancer Spread
    This “Chaos Enzyme” May Hold the Key to Stopping Cancer SpreadOctober 4th, 2025
  • Volastra Announces Initial Data from First-in-Human Phase I/II Trial of Novel KIF18A Inhibitor VLS-1488 to Be Presented at 2025 ASCO Annual Meeting
    Volastra Announces Initial Data from First-in-Human Phase I/II Trial of Novel KIF18A Inhibitor VLS-1488 to Be Presented at 2025 ASCO Annual MeetingMay 22nd, 2025
  • MSK Research Highlights, September 3, 2024
    MSK Research Highlights, September 3, 2024September 3rd, 2024
  • Join now to see all

Research History

  • https://www.mskcc.org/research-areas/labs/samuel-bakhoum

Other Languages

  • French, Italian

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: